The WHO Director-General recently announced ‘he concurs with the advice offered by the Emergency Committee regarding the ongoing COVID-19 pandemic and determines that the event continues to constitute a Public Health Emergency of International Concern.’
CDC Report Addresses Impact of COVID-19 on Antimicrobial Resistance
Increases in resistant infections from 2019 to 2020 seen for carbapenem-resistant Acinetobacter, antifungal-resistant Candida auris
COVID-19 Incidence Not Increased With Corticosteroid Injections
Incidence of COVID-19 lower for adults receiving image-guided corticosteroid injections for pain management
Worldwide Drop in Cancer Screening Seen Early in Pandemic
Significant drops in cancer screening observed for several types of cancer
Spike RBD IgG Antibodies Persist After SARS-CoV-2 Infection
Antibody levels higher for children versus adults across all follow-up time points up to 10 months after infection
Modest Increase Seen in Methadone-Involved OD Deaths in March 2020
Increase in methadone-involved deaths in March 2020 not thought to be tied to expanded opioid treatment program take-home policies
Breakthrough Infections in Lupus Patients Down With COVID Booster
Sixty-four percent of those with breakthrough COVID-19 had received booster compared with 82 percent of those without breakthrough infection